Sympathetic Innervation of the Heart and Cardiac Resynchronization Therapy(CRT)
NCT ID: NCT00567645
Last Updated: 2016-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure Patients
NCT00439790
Ensure Cardiac Resynchronization Therapy Study
NCT00291564
Response To Cardiac Resynchronization Therapy In Heart Failure: Role Of Arterial Stiffness
NCT00970476
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
NCT00359372
Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy
NCT05868616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable optimal medication
* Non ischemic cardiomyopathy
Exclusion Criteria
* Previous CRT
* Clinically relevant valvular heart disease or coronary artery disease
* Acute or chronic infection
* Untreated clinical hypo- or hyperthyroidism or \< 3 months euthyroidism
* Uncontrolled hypertension, defined as a systolic blood pressure \> 160 mm Hg and/or a diastolic blood pressure \> 95 mm Hg
* A concurrent medical condition (i.e. alcohol or drug abuse or a severe progressive extra cardiac disease or M. Parkinson) or is unlikely to comply with the protocol
* Participation to a previous protocol involving radioactivity in the past year
* Pregnancy
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
I.C. Van Gelder
Prof.dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle C. Van Gelder, Prof
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Groningen, departmen cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Groningen
Groningen, Provincie Groningen, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16716
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.